{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:23:31Z","timestamp":1761719011692,"version":"3.44.0"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008235","name":"School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014108","name":"University of Texas Rio Grande Valley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016757","name":"Herb Kosten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA204552","R01 CA206069","R01 CA210192"],"award-info":[{"award-number":["R01 CA204552","R01 CA206069","R01 CA210192"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.lfs.2020.118959","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T11:37:25Z","timestamp":1609155445000},"page":"118959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder"],"prefix":"10.1016","volume":"268","author":[{"given":"Sudhir","family":"Kotnala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupam","family":"Dhasmana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek K.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash C.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali M.","family":"Yallapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena","family":"Jaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118959_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-462003-2.50006-7","article-title":"Molecular biology of cystic fibrosis","author":"Drumm","year":"1993","journal-title":"Molecular genetic medicine: Mol Genet Med"},{"key":"10.1016\/j.lfs.2020.118959_bb0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2223\/JPED.489","article-title":"Cystic fibrosis","volume":"74","author":"Reis","year":"1998","journal-title":"J. Pediatr."},{"key":"10.1016\/j.lfs.2020.118959_bb0015","first-page":"363","article-title":"Origins of cystic fibrosis lung disease","author":"Stoltz","year":"2015","journal-title":"New England Journal of Medicine: Massachussetts Medical Society"},{"key":"10.1016\/j.lfs.2020.118959_bb0020","unstructured":"Cystic Fibrosis Foundation. About cystic fibrosis."},{"key":"10.1016\/j.lfs.2020.118959_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00275","article-title":"CFTR modulators: shedding light on precision medicine for cystic fibrosis","volume":"7","author":"Lopes-Pacheco","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118959_bb0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.biochem.75.103004.142532","article-title":"CFTR function and prospects for therapy","volume":"77","author":"Riordan","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.lfs.2020.118959_bb0035","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.118959_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1242\/jcs.1993.Supplement_17.32","article-title":"Defective acidification of the biosynthetic pathway in cystic fibrosis","author":"Barasch","year":"1993","journal-title":"Journal of Cell Science: J Cell Sci Suppl"},{"key":"10.1016\/j.lfs.2020.118959_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-med-112717-094536","article-title":"Cystic fibrosis: emerging understanding and therapies","volume":"70","author":"Rey","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0050","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1091\/mbc.e08-09-0950","article-title":"Cooperative assembly and misfolding of CFTR domains in vivo","volume":"20","author":"Du","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.lfs.2020.118959_bb0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.molcel.2005.09.007","article-title":"Folding of CFTR is predominantly cotranslational","volume":"20","author":"Kleizen","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.lfs.2020.118959_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsmb882","article-title":"The \u0394F508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR","volume":"12","author":"Du","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118959_bb0065","doi-asserted-by":"crossref","first-page":"35825","DOI":"10.1074\/jbc.M110.131623","article-title":"The cystic fibrosis-causing mutation DELTAF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis","volume":"285","author":"T","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118959_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0925-4439(99)00088-5","article-title":"Expression and intracellular processing of chimeric and mutant CFTR molecules","volume":"1500","author":"Pollet","year":"2000","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2020.118959_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1113\/jphysiol.2002.035790","article-title":"Phosphorylation of protein kinase C sites in NBD1 and the R domain control CFTR channel activation by PKA","author":"Chappe","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2020.118959_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1569-1993(01)00003-0","article-title":"The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions","volume":"1","author":"Vankeerberghen","year":"2002","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0085","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.100588797","article-title":"A functional R domain from cystic fibrosis transmembrane conductance regulator is predominantly unstructured in solution","volume":"97","author":"Ostedgaard","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118959_bb0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0005-2736(99)00163-7","article-title":"Influence of phosphorylation by protein kinase a on CFTR at the cell surface and endoplasmic reticulum","author":"Seibert","year":"1999","journal-title":"Biochimica et Biophysica Acta - Biomembranes: Biochim Biophys Acta"},{"key":"10.1016\/j.lfs.2020.118959_bb0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2017.06.041","article-title":"Conformational changes of CFTR upon phosphorylation and ATP binding","volume":"170","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118959_bb0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.10041","article-title":"Cystic fibrosis: a worldwide analysis of CFTR mutations - correlation with incidence data and application to screening","volume":"19","author":"Bobadilla","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.lfs.2020.118959_bb0105","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s004310051317","article-title":"The geographic distribution of cystic fibrosis mutations gives clues about population origins","volume":"159","author":"Dawson","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.lfs.2020.118959_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcf.2005.05.006","article-title":"Disease modifying genes in cystic fibrosis","volume":"4","author":"Slieker","year":"2005","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0115","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.lfs.2020.118959_bb0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molmed.2011.10.003","article-title":"CFTR: folding, misfolding and correcting the \u0394F508 conformational defect","volume":"18","author":"Lukacs","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cell.2011.11.023","article-title":"Requirements for efficient correction of \u0394f508 CFTR revealed by analyses of evolved sequences","volume":"148","author":"Mendoza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118959_bb0130","doi-asserted-by":"crossref","first-page":"14848","DOI":"10.1074\/jbc.M011017200","article-title":"Disease-associated mutations in the extracytoplasmic loops of cystic fibrosis transmembrane conductance regulator do not impede biosynthetic processing but impair chloride channel stability","volume":"276","author":"H\u00e4mmerle","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118959_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/362160a0","article-title":"Mutations in CFTR associated with mild-disease-form CI- channels with altered pore properties","volume":"362","author":"Sheppard","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118959_bb0140","doi-asserted-by":"crossref","first-page":"11554","DOI":"10.1074\/jbc.M212843200","article-title":"A mutation in the cystic fibrosis transmembrane conductance regulator generates a novel internalization sequence and enhances endocytic rates","volume":"278","author":"Silvis","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118959_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00374371","article-title":"Na+ and Cl\u2212 conductances in airway epithelial cells: increased Na+ conductance in cystic fibrosis","volume":"431","author":"Kunzelmann","year":"1995","journal-title":"Pfl\u00fcgers Archiv European Journal of Physiology."},{"key":"10.1016\/j.lfs.2020.118959_bb0150","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aad5589","article-title":"Airway acidification initiates host defense abnormalities in cystic fibrosis mice","volume":"351","author":"Shah","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.118959_bb0155","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI83922","article-title":"Acidic pH increases airway surface liquid viscosity in cystic fibrosis","volume":"126","author":"Tang","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2020.118959_bb0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1183\/09059180.00006512","article-title":"Treatment of pulmonary exacerbations in cystic fibrosis","volume":"22","author":"Bhatt","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.lfs.2020.118959_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI0213870","article-title":"Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients","volume":"109","author":"Worlitzsch","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2020.118959_bb0170","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ppul.20646","article-title":"The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation","volume":"42","author":"Downey","year":"2007","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118959_bb0175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jcf.2009.06.001","article-title":"Serum matrix metalloproteinases in adult CF patients: relation to pulmonary exacerbation","volume":"8","author":"Roderfeld","year":"2009","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0180","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1513\/pats.200703-044BR","article-title":"Sputum biomarkers of inflammation in cystic fibrosis lung disease","volume":"4","author":"Sagel","year":"2007","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.lfs.2020.118959_bb0185","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1378\/chest.13-0588","article-title":"Automated ct scan scores of bronchiectasis and air trapping in cystic fibrosis","volume":"145","author":"DeBoer","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2020.118959_bb0190","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/rccm.200609-1354OC","article-title":"Association between pulmonary function and sputum biomarkers in cystic fibrosis","volume":"175","author":"Mayer-Hamblett","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0195","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.201203-0507OC","article-title":"Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis","volume":"186","author":"Sagel","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0200","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk factors for bronchiectasis in children with cystic fibrosis","volume":"368","author":"Sly","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0205","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ppul.22525","article-title":"Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation","volume":"47","author":"Laguna","year":"2012","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118959_bb0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1440-1843.2006.00962.x","article-title":"Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis","volume":"12","author":"Reid","year":"2007","journal-title":"Respirology"},{"key":"10.1016\/j.lfs.2020.118959_bb0215","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1399-3038.2007.00693.x","article-title":"Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children","volume":"19","author":"Robroeks","year":"2008","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.lfs.2020.118959_bb0220","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.293.5.581","article-title":"Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis","volume":"293","author":"Li","year":"2005","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.lfs.2020.118959_bb0225","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1183\/09031936.01.00068901","article-title":"Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF","volume":"18","author":"Navarro","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2020.118959_bb0230","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ppul.21350","article-title":"Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection","volume":"46","author":"Moskowitz","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118959_bb0235","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jcf.2016.05.001","article-title":"Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosis","volume":"15","author":"Flume","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-13-143","article-title":"Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis","volume":"13","author":"Le Gall","year":"2013","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.lfs.2020.118959_bb0245","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI0215217","article-title":"Mucus clearance as a primary innate defense mechanism for mammalian airways","volume":"109","author":"Knowles","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2020.118959_bb0250","first-page":"S177","article-title":"Unplugging mucus in cystic fibrosis and chronic obstructive pulmonary disease","volume":"13","author":"Mall","year":"2016","journal-title":"Ann Am Thorac Soc."},{"key":"10.1016\/j.lfs.2020.118959_bb0255","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009589","article-title":"CFTR, mucins, and mucus obstruction in cystic fibrosis","volume":"2","author":"Kreda","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.lfs.2020.118959_bb0260","doi-asserted-by":"crossref","first-page":"L92","DOI":"10.1152\/ajplung.90388.2008","article-title":"Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways?","volume":"296","author":"Kesimer","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.lfs.2020.118959_bb0265","first-page":"189","article-title":"Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases","volume":"1765","author":"Andrianifahanana","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2020.118959_bb0270","first-page":"G613","article-title":"Mucin gene structure and expression: protection vs. adhesion","volume":"269","author":"Van Klinken","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2020.118959_bb0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00010.2005","article-title":"Respiratory tract mucin genes and mucin glycoproteins in health and disease","volume":"86","author":"Rose","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2020.118959_bb0280","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1073\/pnas.1703228114","article-title":"Gel-forming mucins form distinct morphologic structures in airways","volume":"114","author":"Ostedgaard","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118959_bb0285","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1164\/rccm.200607-1011OC","article-title":"MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation","volume":"175","author":"Henke","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0290","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1172\/JCI3820","article-title":"Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus","volume":"102","author":"Parmley","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.118959_bb0295","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00418-010-0688-8","article-title":"The characterization of the first anti-mouse Muc6 antibody shows an increased expression of the mucin in pancreatic tissue of Cftr-knockout mice","volume":"133","author":"Gouyer","year":"2010","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118959_bb0300","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2020.118959_bb0305","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.lfs.2020.118959_bb0310","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2020.118959_bb0315","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s00535-013-0885-z","article-title":"Functions and regulation of MUC13 mucin in colon cancer cells","volume":"49","author":"Gupta","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.lfs.2020.118959_bb0320","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbamcr.2013.12.013","article-title":"Disrupted interaction between CFTR and AF-6\/afadin aggravates malignant phenotypes of colon cancer","volume":"1843","author":"Sun","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2020.118959_bb0325","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ajhg.2013.07.018","article-title":"Mutations in IMPG1 cause vitelliform macular dystrophies","volume":"93","author":"Manes","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.lfs.2020.118959_bb0330","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/10715762.2014.904043","article-title":"Macular pigment and macular volume in eyes of patients with cystic fibrosis","volume":"48","author":"Shi","year":"2014","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.lfs.2020.118959_bb0335","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1167\/iovs.14-14129","article-title":"IMPG2-associated retinitis pigmentosa displays relatively early macular involvement","volume":"55","author":"van Huet","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.lfs.2020.118959_bb0340","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1164\/rccm.200202-087OC","article-title":"Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality","volume":"166","author":"Mayer-Hamblett","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0345","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1164\/rccm.200407-900OC","article-title":"Use of lung transplantation survival models to refine patient selection in cystic fibrosis","volume":"171","author":"Liou","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0350","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3201\/eid0912.020774","article-title":"Mycobacterium abscessus and children with cystic fibrosis","volume":"9","author":"Sermet-Gaudelus","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118959_bb0355","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1164\/ajrccm.161.2.9903062","article-title":"Mycobacterium abscessus infection in cystic fibrosis: colonization or infection?","volume":"161","author":"Cullen","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0360","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/319987","article-title":"Nontuberculous mycobacteria in patients with cystic fibrosis","volume":"32","author":"Oliver","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118959_bb0365","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ppul.20336","article-title":"Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections","volume":"40","author":"Bodini","year":"2005","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118959_bb0370","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1128\/JCM.37.10.3167-3170.1999","article-title":"Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients","volume":"37","author":"LiPuma","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.lfs.2020.118959_bb0375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K","article-title":"Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis","volume":"21","author":"Armstrong","year":"1996","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118959_bb0380","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ppul.1144","article-title":"Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis","volume":"32","author":"Rosenfeld","year":"2001","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118959_bb0385","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10096-008-0605-4","article-title":"Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients","volume":"28","author":"Spicuzza","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118959_bb0390","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/bmb\/61.1.81","article-title":"Persistent and aggressive bacteria in the lungs of cystic fibrosis children","volume":"61","author":"Hart","year":"2002","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.lfs.2020.118959_bb0395","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/thx.2005.054726","article-title":"Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population","volume":"61","author":"Tramper-Stranders","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.118959_bb0400","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1086\/318075","article-title":"Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis","volume":"183","author":"Burns","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118959_bb0405","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/416740a","article-title":"Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation","volume":"416","author":"Drenkard","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.118959_bb0410","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jcf.2006.10.007","article-title":"Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center","volume":"6","author":"Kennedy","year":"2007","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0415","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4103\/0019-5359.33194","article-title":"Burkholderia cepacia complex: virulence characteristics, importance and relationship with cystic fibrosis","volume":"61","author":"Melo Coutinho","year":"2007","journal-title":"Indian J. Med. Sci."},{"key":"10.1016\/j.lfs.2020.118959_bb0420","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1128\/JCM.41.9.4009-4015.2003","article-title":"Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis","volume":"41","author":"Miller","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.lfs.2020.118959_bb0425","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1128\/JCM.01604-13","article-title":"Chronic rhinovirus infection in an adult with cystic fibrosis","volume":"51","author":"Flight","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.lfs.2020.118959_bb0430","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3201\/eid1606.100063","article-title":"Rhinovirus C and respiratory exacerbations in children with cystic fibrosis","volume":"16","author":"de Almeida","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118959_bb0435","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jcf.2007.05.002","article-title":"Is there a role for influenza vaccination in cystic fibrosis?","volume":"7","author":"Wat","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0440","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jviromet.2012.08.008","article-title":"Detection of viral and bacterial respiratory pathogens in patients with cystic fibrosis","volume":"186","author":"Stelzer-Braid","year":"2012","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.lfs.2020.118959_bb0445","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1542\/peds.2007-3139","article-title":"Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study","volume":"122","author":"Van Ewijk","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.lfs.2020.118959_bb0450","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/irv.12353","article-title":"Rhinovirus-associated pulmonary exacerbations show a lack of FEV1 improvement in children with cystic fibrosis","volume":"10","author":"Cousin","year":"2016","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.lfs.2020.118959_bb0455","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/thx.2010.157032","article-title":"Influenza A\/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study","volume":"66","author":"Colombo","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.118959_bb0460","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-10-8","article-title":"The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis","volume":"10","author":"France","year":"2010","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1016\/j.lfs.2020.118959_bb0465","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcf.2011.06.004","article-title":"Impact of the A (H1N1) pandemic influenza (season 2009\u20132010) on patients with cystic fibrosis","volume":"10","author":"Viviani","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0470","first-page":"662","article-title":"The effect of respiratory viral infections on patients with cystic fibrosis","volume":"143","author":"Ramsey","year":"1989","journal-title":"American Journal of Diseases of Children"},{"key":"10.1016\/j.lfs.2020.118959_bb0475","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jcf.2014.11.009","article-title":"Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations","volume":"14","author":"Chin","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0480","first-page":"800","article-title":"New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus","volume":"42","author":"Lay","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2020.118959_bb0485","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcf.2012.04.006","article-title":"Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis","volume":"11","author":"Asner","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0490","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/infdis\/jis274","article-title":"The differential clinical impact of human coronavirus species in children with cystic fibrosis","volume":"206(3)","author":"Da Silva Filho","year":"2012","journal-title":"J Infect Dis."},{"key":"10.1016\/j.lfs.2020.118959_bb0495","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01780642","article-title":"Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer","volume":"24","author":"Rosenecker","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.lfs.2020.118959_bb0500","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2013-204000","article-title":"Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis","volume":"69","author":"Flight","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.118959_bb0505","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ppul.20546","article-title":"Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis","volume":"42","author":"Garcia","year":"2007","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118959_bb0510","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2213-2600(20)30177-6","article-title":"Impact of COVID-19 on people with cystic fibrosis","author":"Colombo","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0515","article-title":"Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis","volume":"18: 311.","author":"Eikani","year":"2018","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.lfs.2020.118959_bb0520","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11908-010-0103-6","article-title":"Pulmonary Nontuberculous Mycobacterial Disease: New Insights into Risk Factors for Susceptibility, Epidemiology, and Approaches to Management in Immunocompetent and Immunocompromised Patients","volume":"12(3)","author":"Saleeb","year":"2010","journal-title":"Curr Infect Dis Rep."},{"key":"10.1016\/j.lfs.2020.118959_bb0525","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1099\/00222615-45-4-294","article-title":"Persistence of Staphylococcus aureus strains among cystic fibrosis patients over extended periods of time","volume":"45","author":"Branger","year":"1996","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.lfs.2020.118959_bb0530","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1183\/09031936.04.00049104","article-title":"Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis","volume":"24","author":"Aaron","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2020.118959_bb0535","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201810-1919OC","article-title":"Changing Prevalence of Lower Airway Infections in Young Children with Cystic Fibrosis","volume":"200(5)","author":"Breuer","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0540","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/706376","article-title":"2015;2015:706376. The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi)","volume":"2015","author":"King","year":"2015","journal-title":"J Immunol Res."},{"key":"10.1016\/j.lfs.2020.118959_bb0545","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1183\/09031936.00161907","article-title":"Serial viral infections in infants with recurrent respiratory illnesses","volume":"32","author":"Jartti","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2020.118959_bb0550","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2222.2005.02244.x","article-title":"Persistence of rhinovirus RNA after asthma exacerbation in children","volume":"35","author":"Kling","year":"2005","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.lfs.2020.118959_bb0555","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0022-3476(88)80008-8","article-title":"Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis","volume":"113","author":"Abman","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.lfs.2020.118959_bb0560","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1378\/chest.09-1374","article-title":"Influenza-associated cystic fibrosis pulmonary exacerbations","volume":"137","author":"Ortiz","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2020.118959_bb0565","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.3390\/v5092260","article-title":"Respiratory syncytial virus infection disrupts monolayer integrity and function in cystic fibrosis airway cells","volume":"5","author":"Kong","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2020.118959_bb0570","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1556\/EuJMI.2.2012.3.1","article-title":"Spectrum of viral infections in patients with cystic fibrosis","volume":"2(3)","author":"Frickmann","year":"2012","journal-title":"Eur J Microbiol Immunol (Bp)."},{"key":"10.1016\/j.lfs.2020.118959_bb0575","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/CVI.00750-12","article-title":"Seroepidemiologies of human metapneumovirus and respiratory syncytial virus in young children, determined with a new recombinant fusion protein enzyme-linked immunosorbent assay","volume":"20(10)","author":"Dunn","year":"2013","journal-title":"Clin Vaccine Immunol ."},{"key":"10.1016\/j.lfs.2020.118959_bb0580","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7883\/yoken.67.399","article-title":"Human rhinovirus infection in children with cystic fibrosis","volume":"67","author":"Esposito","year":"2014","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118959_bb0585","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/1040841X.2017.1297763","article-title":"Viruses in cystic fibrosis patients\u2019 airways","volume":"43(6)","author":"Billard","year":"2017","journal-title":"Crit Rev Microbiol."},{"key":"10.1016\/j.lfs.2020.118959_bb0590","first-page":"607","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Inf. Secur."},{"issue":"4","key":"10.1016\/j.lfs.2020.118959_bb0595","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41435-020-0103-y","article-title":"COVID-19 meets cystic fibrosis: for better or worse?","author":"Peckham","year":"2020","journal-title":"Genes Immun."},{"key":"10.1016\/j.lfs.2020.118959_bb0600","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54556","article-title":"Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis","volume":"9","author":"Jarosz-Griffiths","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.lfs.2020.118959_bb0605","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"9","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.lfs.2020.118959_bb0610","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49248","article-title":"ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis","volume":"8","author":"Scambler","year":"2019","journal-title":"Elife."},{"key":"10.1016\/j.lfs.2020.118959_bb0615","first-page":"1","article-title":"Angiotensin receptor blockers as tentative SARSCoV-2 therapeutics","volume":"10","author":"G.","year":"2020","journal-title":"Drug Dev. Res."},{"issue":"6","key":"10.1016\/j.lfs.2020.118959_bb0620","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jmv.25757","article-title":"COVID-19 patients\u2019 clinical characteristics, discharge rate, and fatality rate of meta-analysis","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.lfs.2020.118959_bb0625","doi-asserted-by":"crossref","first-page":"802.26","DOI":"10.1096\/fasebj.2019.33.1_supplement.802.26","article-title":"Furin inhibition as a mechanism to reduce aberrant ENaC-mediated sodium transport and rehydrate the airways in cystic fibrosis lung disease","volume":"33","author":"Douglas","year":"2019","journal-title":"FASEB."},{"key":"10.1016\/j.lfs.2020.118959_bb0630","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1183\/09031936.00196314","article-title":"Future trends in cystic fibrosis demography in 34 European countries","volume":"46","author":"Burgel","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2020.118959_bb0635","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0035-1546821","article-title":"Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning","volume":"36","author":"Barry","year":"2015","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.lfs.2020.118959_bb0640","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jcf.2013.10.011","article-title":"Sinonasal manifestations of cystic fibrosis: a correlation between genotype and phenotype?","volume":"13","author":"Berkhout","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0645","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02914539","article-title":"Upper respiratory disease, sinusitis, and polyposis","volume":"9","author":"King","year":"1991","journal-title":"Clin. Rev. Allergy"},{"key":"10.1016\/j.lfs.2020.118959_bb0650","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archotol.128.11.1245","article-title":"Children with cystic fibrosis: who should visit the otorhinolaryngologist?","volume":"128","author":"Slieker","year":"2002","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.lfs.2020.118959_bb0655","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1007\/s00405-014-3446-z","article-title":"Nasal endoscopy and paranasal sinus computerised tomography (CT) findings in an Irish cystic fibrosis adult patient group","volume":"272","author":"Casserly","year":"2015","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.lfs.2020.118959_bb0660","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI110894","article-title":"Relative ion permeability of normal and cystic fibrosis nasal epithelium","volume":"71","author":"Knowles","year":"1983","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2020.118959_bb0665","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2500\/ajra.2013.27.3919","article-title":"Cystic fibrosis chronic rhinosinusitis: a comprehensive review","volume":"27","author":"Chaaban","year":"2013","journal-title":"American Journal of Rhinology and Allergy"},{"key":"10.1016\/j.lfs.2020.118959_bb0670","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/coa.12310","article-title":"Ivacaftor improves appearance of sinus disease on computerised tomography in cystic fibrosis patients with G551D mutation","volume":"40","author":"Sheikh","year":"2015","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.lfs.2020.118959_bb0675","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jpeds.2005.11.032","article-title":"Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital","volume":"148","author":"Raffini","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.lfs.2020.118959_bb0680","first-page":"7","article-title":"Guidelines for the management of pregnancy in women with cystic fibrosis","author":"Edenborough","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0685","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1378\/chest.115.5.1321","article-title":"Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia","volume":"115","author":"Fraser","year":"1999","journal-title":"Chest."},{"key":"10.1016\/j.lfs.2020.118959_bb0690","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1378\/chest.128.2.729","article-title":"Massive hemoptysis in cystic fibrosis","volume":"128","author":"Flume","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2020.118959_bb0695","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ppul.1950150311","article-title":"Cystic fibrosis foundation consensus conference report on pulmonary complications of cystic fibrosis","volume":"15","author":"Schidlow","year":"1993","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118959_bb0700","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MCP.0b013e328345e1f8","article-title":"Pneumothorax in cystic fibrosis","volume":"17","author":"Flume","year":"2011","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0705","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.gastro.2003.08.016","article-title":"Discussion on genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis [4]","volume":"125","author":"Dray","year":"2003","journal-title":"Gastroenterology."},{"key":"10.1016\/j.lfs.2020.118959_bb0710","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MEG.0b013e3282f36d16","article-title":"The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype","volume":"20","author":"Walkowiak","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2020.118959_bb0715","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-3476(64)80351-6","article-title":"Light and electron microscopic examination of the small bowel of children with cystic fibrosis","volume":"64","author":"Freye","year":"1964","journal-title":"J. Pediatr."},{"key":"10.1016\/j.lfs.2020.118959_bb0720","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1569-1993(02)00032-2","article-title":"Nutrition in patients with cystic fibrosis: a European consensus","volume":"1","author":"Sinaasappel","year":"2002","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0725","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(15)00545-7","article-title":"Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study","volume":"4","author":"Davies","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0730","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(16)30032-7","article-title":"Partial restoration of pancreatic function in a child with cystic fibrosis","volume":"4","author":"Howlett","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0735","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1053\/gast.2002.37042","article-title":"Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis","volume":"123","author":"Durno","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2020.118959_bb0740","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/eje.0.1490053","article-title":"Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia","volume":"149","author":"Lombardo","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.lfs.2020.118959_bb0745","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1651-2227.1993.tb12653.x","article-title":"Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up","volume":"82","author":"Arrigo","year":"1993","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.lfs.2020.118959_bb0750","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2020.118959_bb0755","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.diabet.2008.05.010","article-title":"No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes","volume":"34","author":"Godbout","year":"2008","journal-title":"Diabetes and Metabolism"},{"key":"10.1016\/j.lfs.2020.118959_bb0760","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcf.2015.03.013","article-title":"HbA1c as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Burgess","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0765","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcf.2015.10.009","article-title":"Using HbA1c as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Widger","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0770","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jcf.2015.10.010","article-title":"HbA1c: an effective screening tool for cystic fibrosisrelated diabetes?","author":"Schnyder","year":"2016","journal-title":"Journal of Cystic Fibrosis: Elsevier B.V"},{"key":"10.1016\/j.lfs.2020.118959_bb0775","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0739-5930(10)79557-X","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"2010","author":"Harnois","year":"2010","journal-title":"Yearbook of Gastroenterology"},{"key":"10.1016\/j.lfs.2020.118959_bb0780","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2020.118959_bb0785","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.1840160215","article-title":"Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis","volume":"16","author":"Lindblad","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2020.118959_bb0790","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jhep.2011.03.028","article-title":"Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation","volume":"55","author":"Chryssostalis","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2020.118959_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0800","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1542\/peds.78.3.473","article-title":"Constipation and meconium ileus equivalent in patients with cystic fibrosis","volume":"78","author":"Rubinstein","year":"1986","journal-title":"Pediatrics."},{"key":"10.1016\/j.lfs.2020.118959_bb0805","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1651-2227.1962.tb06550.x","article-title":"Meconium-ileus equivalent in a 15-year-old patient with mucoviscidosis","volume":"51","author":"Jensen","year":"1962","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.lfs.2020.118959_bb0810","first-page":"299","article-title":"Incidence of distal intestinal obstruction syndrome in cystic fibrosis","volume":"2","author":"Rosenstein","year":"1983","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.lfs.2020.118959_bb0815","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MPG.0b013e3181acae98","article-title":"Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis","volume":"50","author":"Blondeau","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.lfs.2020.118959_bb0820","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1378\/chest.11-1573","article-title":"Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis","volume":"141","author":"Pauwels","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2020.118959_bb0825","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198808043190502","article-title":"Microscopic nephrocalcinosis in cystic fibrosis","volume":"319","author":"Katz","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0830","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ppul.20138","article-title":"Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use","volume":"39","author":"Al-Aloul","year":"2005","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118959_bb0835","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/thx.2006.067595","article-title":"Survey of acute renal failure in patients with cystic fibrosis in the UK","volume":"62","author":"Bertenshaw","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.118959_bb0840","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1008634911114","article-title":"Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis","volume":"20","author":"Touw","year":"1998","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.lfs.2020.118959_bb0845","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(05)17906-9","article-title":"Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis - the TOPIC study: a randomised controlled trial","volume":"365","author":"Smyth","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.118959_bb0850","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201105-0932OC","article-title":"Risk factors for chronic kidney disease in adults with cystic fibrosis","volume":"184","author":"Quon","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0855","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.11-1926","article-title":"Risk of post-lung transplant renal dysfunction in adults with cystic fibrosis","volume":"142","author":"Quon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2020.118959_bb0860","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1099-0496(199804)25:4<226::AID-PPUL2>3.0.CO;2-I","article-title":"Reproductive health in males with cystic fibrosis: knowledge, attitudes, and experiences of patients and parents","volume":"25","author":"Sawyer","year":"1998","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.lfs.2020.118959_bb0865","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/ajrccm.153.2.8564145","article-title":"Cystic fibrosis 3849+10kb C > T mutation associated with severe pulmonary disease and male fertility","volume":"153","author":"Dreyfus","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0870","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcf.2010.07.001","article-title":"Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients","volume":"9","author":"Siklosi","year":"2010","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb0875","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1742-1241.2003.tb10460.x","article-title":"Incontinence in adult females with cystic fibrosis: a Northern Ireland survey","volume":"57","author":"Moran","year":"2003","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.lfs.2020.118959_bb0880","first-page":"166","article-title":"Prevalence and impact of urinary incontinence in men with cystic fibrosis","volume":"101","author":"Burge","year":"2015","journal-title":"Physiotherapy (United Kingdom)"},{"key":"10.1016\/j.lfs.2020.118959_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-009-9316-9","article-title":"The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis","volume":"86","author":"Paccou","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.lfs.2020.118959_bb0890","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/thx.2005.046516","article-title":"Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis","volume":"61","author":"Buntain","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.118959_bb0895","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/thx.2006.075887","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone [1]","volume":"62","author":"Shead","year":"2007","journal-title":"Thorax."},{"key":"10.1016\/j.lfs.2020.118959_bb0900","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","volume":"2014","author":"Conwell","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2020.118959_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/S1569-1993(11)60004-0","article-title":"European cystic fibrosis bone mineralisation guidelines","volume":"10","author":"Sermet-Gaudelus","year":"2011","journal-title":"J. Cyst. Fibros."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2020.118959_bb0910","first-page":"38","article-title":"Cancer risk in patients with cystic fibrosis: the European data. CF\/CSG Group","volume":"89","author":"Schoni","year":"1996","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0915","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gut.2004.062786","article-title":"Patterns of GI disease in adulthood associated with mutations in the CFTR gene","volume":"56","author":"Wilschanski","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2020.118959_bb0920","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/ijc.24679","article-title":"Cancer risk among patients with cystic fibrosis and their first-degree relatives","volume":"125","author":"Johannesson","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118959_bb0925","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/pros.22833","article-title":"A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis","volume":"74","author":"Ashour","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.lfs.2020.118959_bb0930","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/jcm9030734","article-title":"Epigenetic modification of CFTR in head and neck cancer","volume":"9","author":"Shin","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2020.118959_bb0935","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00339","article-title":"Differential gene expression landscape of co-existing cervical pre-cancer lesions using RNA-seq","volume":"4","author":"Royse","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2020.118959_bb0940","doi-asserted-by":"crossref","first-page":"966","DOI":"10.12659\/MSM.899341","article-title":"Lower cystic fibrosis transmembrane conductance regulator (CFTR) promotes the proliferation and migration of endometrial carcinoma","volume":"23","author":"Xia","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.lfs.2020.118959_bb0945","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.3748\/wjg.v10.i23.3433","article-title":"Methylation profile of the promoter CpG islands of 14 \u201cdrug-resistance\u201d genes in hepatocellular carcinoma","volume":"10","author":"Ding","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2020.118959_bb0950","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2020.118959_bb0955","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1038\/onc.2012.251","article-title":"CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer","volume":"32","author":"Xie","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2020.118959_bb0960","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1158\/1078-0432.CCR-07-0861","article-title":"A novel set of DNA methylation markers in urine sediments for sensitive\/specific detection of bladder cancer","volume":"13","author":"Yu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118959_bb0965","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000348439","article-title":"Clinical and morphological characteristics of sporadic genetically determined pancreatitis as compared to idiopathic pancreatitis: higher risk of pancreatic cancer in CFTR variants","volume":"87","author":"Hamoir","year":"2013","journal-title":"Digestion"},{"key":"10.1016\/j.lfs.2020.118959_bb0970","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cncr.24697","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma","volume":"116(1)","author":"McWilliams","year":"2010","journal-title":"Cancer."},{"key":"10.1016\/j.lfs.2020.118959_bb0975","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbamcr.2013.12.013","article-title":"Disrupted interaction between CFTR and AF-6\/afadin aggravates malignant phenotypes of colon cancer","volume":"1843","author":"Sun","year":"2014","journal-title":"Biochimica et Biophysica Acta - Molecular Cell Research"},{"key":"10.1016\/j.lfs.2020.118959_bb0980","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3892\/ijo.2015.2921","article-title":"The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer","volume":"46","author":"Li","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2020.118959_bb0985","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/jtd.2017.01.04","article-title":"Weighted gene co-expression network analysis in identification of metastasis-related genes of lung squamous cell carcinoma based on the Cancer Genome Atlas database","volume":"9","author":"Tian","year":"2017","journal-title":"Journal of Thoracic Disease"},{"key":"10.1016\/j.lfs.2020.118959_bb0990","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.bbamcr.2013.07.021","article-title":"Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer","volume":"1833","author":"Zhang","year":"2013","journal-title":"Biochimica et Biophysica Acta - Molecular Cell Research"},{"key":"10.1016\/j.lfs.2020.118959_bb0995","article-title":"CFTR deltaF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control study","volume":"79","author":"S.","year":"1998","journal-title":"Int. J. Cancer"},{"year":"2020","series-title":"Drug Development Pipeline","author":"Cystic Fibrosis Foundation","key":"10.1016\/j.lfs.2020.118959_bb1000"},{"key":"10.1016\/j.lfs.2020.118959_bb1005","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fbioe.2019.00406","article-title":"Nanomedicine approaches for the pulmonary treatment of cystic fibrosis","volume":"7","author":"Velino","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"10.1016\/j.lfs.2020.118959_bb1010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/2472630318824334","article-title":"Nanomedicine for cystic fibrosis","volume":"24","author":"Ong","year":"2019","journal-title":"SLAS Technol"},{"key":"10.1016\/j.lfs.2020.118959_bb1015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/BJ20110672","article-title":"MicroRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene","volume":"438","author":"Gillen","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2020.118959_bb1020","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ajpath.2014.12.022","article-title":"New insights about miRNAs in cystic fibrosis","volume":"185","author":"Sonneville","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2020.118959_bb1025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1183\/09031936.00113214","article-title":"Transcription factors and miRNAs that regulate fetal to adult CFTR expression change are new targets for cystic fibrosis","volume":"45","author":"Viart","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2020.118959_bb1030","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1165\/rcmb.2012-0430OC","article-title":"Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs","volume":"49","author":"Ramachandran","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118959_bb1035","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.4049\/jimmunol.1202960","article-title":"Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in \u0394F508 cystic fibrosis airway epithelium","volume":"190","author":"Oglesby","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118959_bb1040","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25071677","article-title":"A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3\u2032UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells","volume":"25","author":"Sultan","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2020.118959_bb1045","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ymthe.2020.02.001","article-title":"Precise targeting of miRNA sites restores CFTR activity in CF bronchial epithelial cells","volume":"28","author":"De Santi","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2020.118959_bb1050","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ymthe.2018.11.017","article-title":"A neutralizing aptamer to TGFBR2 and miR-145 antagonism rescue cigarette smoke- and TGF-\u03b2-mediated CFTR expression","volume":"27","author":"Dutta","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2020.118959_bb1055","doi-asserted-by":"crossref","DOI":"10.1186\/s40348-014-0012-0","article-title":"miRNA-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression of ATF6","volume":"2","author":"Oglesby","year":"2015","journal-title":"Mol Cell Pediatr"},{"key":"10.1016\/j.lfs.2020.118959_bb1060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1165\/rcmb.2018-0114OC","article-title":"Cystic fibrosis plasma blunts the immune response to bacterial infection","volume":"61","author":"Zhang","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.lfs.2020.118959_bb1065","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/15476286.2016.1197484","article-title":"RPTOR, a novel target of miR-155, elicits a fibrotic phenotype of cystic fibrosis lung epithelium by upregulating CTGF","volume":"13","author":"Tsuchiya","year":"2016","journal-title":"RNA Biol."},{"key":"10.1016\/j.lfs.2020.118959_bb1070","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2016-2431","article-title":"miR-146a, miR-155, miR-370, and miR-708 are CFTR-dependent, predicted FOXO1 regulators and change at onset of CFRDs","volume":"101","author":"Montanini","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2020.118959_bb1075","doi-asserted-by":"crossref","first-page":"F993","DOI":"10.1152\/ajprenal.00450.2018","article-title":"Loss of miR-17~92 results in dysregulation of Cftr in nephron progenitors","volume":"316","author":"Phua","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.lfs.2020.118959_bb1080","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jcf.2017.11.005","article-title":"The expression of Mirc1\/Mir17-92 cluster in sputum samples correlates with pulmonary exacerbations in cystic fibrosis patients","volume":"17","author":"Krause","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2020.118959_bb1085","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1080\/15548627.2016.1217370","article-title":"Elevated Mirc1\/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages","volume":"12","author":"Tazi","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2020.118959_bb1090","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1183\/09031936.00163414","article-title":"miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production","volume":"46","author":"Oglesby","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2020.118959_bb1095","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2217\/epi-2016-0088","article-title":"Noncoding RNAs and Duchenne muscular dystrophy","volume":"8","author":"Perry","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.lfs.2020.118959_bb1100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","article-title":"Evolution and functions of long noncoding RNAs","volume":"136","author":"Ponting","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118959_bb1105","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2013.02.012","article-title":"Long noncoding RNAs: cellular address codes in development and disease","volume":"152","author":"Batista","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118959_bb1110","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tcb.2011.04.001","article-title":"Long noncoding RNAs and human disease","volume":"21","author":"Wapinski","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.lfs.2020.118959_bb1115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biocel.2014.02.022","article-title":"Long noncoding RNA are aberrantly expressed in vivo in the cystic fibrosis bronchial epithelium","volume":"52","author":"McKiernan","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118959_bb1120","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/mt.2016.112","article-title":"Long non-coding RNA BGas regulates the cystic fibrosis transmembrane conductance regulator","volume":"24","author":"Saayman","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2020.118959_bb1125","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1259-8","article-title":"Comparative analyses of long non-coding RNA profiles in vivo in cystic fibrosis lung airway and parenchyma tissues","volume":"20","author":"Kumar","year":"2019","journal-title":"Respir. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520317197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520317197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:39:31Z","timestamp":1758400771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520317197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":225,"alternative-id":["S0024320520317197"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118959","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118959"}}